PKTXOTCPharmaceutical PreparationsFiscal year ends December 31
ProtoKinetix, Inc.
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 10-K on Sep 3, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $78.61K
- P/E (TTM)
- –
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Dec 31, 2025
ProtoKinetix reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in ProtoKinetix's annual report. Trading prices and yields need FINRA TRACE data.